Controlled Clinical Trials as Topic
-
Subject Areas on Research
- A compendium of placebo-controlled trials of the risks/benefits of pharmacological treatments for insomnia: the empirical basis for U.S. clinical practice.
- A note on sample size calculation based on propensity analysis in nonrandomized trials.
- Analysis of time-to-event data under a two-stage survival adaptive design in clinical trials.
- Analysis of time-to-event data with nonuniform patient entry and loss to follow-up under a two-stage seamless adaptive design with weibull distribution.
- Assessing departure from dose linearity under a repeated measures incomplete block design.
- Assessing exertional dyspnea in patients with idiopathic pulmonary fibrosis.
- Authorship in a multicenter clinical trial: The Heart Failure-A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) Authorship and Publication (HAP) scoring system results.
- Basic concepts in cellular cardiac electrophysiology: Part II: Block of ion channels by antiarrhythmic drugs.
- CBT versus supportive therapy for depression.
- Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study).
- Cognitive behavioral control of arthritis pain.
- Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review.
- Control arms in exercise training studies: transitioning from an era of intervention efficacy to one of comparative clinical effectiveness research.
- Controlled human exposures to ambient pollutant particles in susceptible populations.
- Designs in partially controlled studies: messages from a review.
- Dextranomer/hyaluronic acid for pediatric vesicoureteral reflux: systematic review.
- Effect of angiotensin-converting enzyme inhibitors on progression of nondiabetic renal disease.
- Effectiveness of anti-TNFα for Crohn disease: research in a pediatric learning health system.
- Epoetin treatment of anemia associated with cancer therapy: a systematic review and meta-analysis of controlled clinical trials.
- Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention.
- Fibrinolysis for acute myocardial infarction: current status and new horizons for pharmacological reperfusion, part 1.
- First-line pharmacotherapy approaches for generalized anxiety disorder.
- From controlled trials to clinical practice: monitoring transmyocardial revascularization use and outcomes.
- Graphical search for two-stage designs for phase II clinical trials.
- Impact of patient navigation on timely cancer care: the Patient Navigation Research Program.
- Instability after total hip arthroplasty: treatment with large femoral heads vs constrained liners.
- L-carnitine.
- Lessons From the Testosterone Trials.
- Leveraging external data in the design and analysis of clinical trials in neuro-oncology.
- Management of uterine leiomyomata: what do we really know?
- Medium matters: modeling the impact of solid medium performance on tuberculosis trial sample size requirements.
- Mixed noninferiority margin and statistical tests in active controlled trials.
- Molecular genetics of successful smoking cessation: convergent genome-wide association study results.
- Monoclonal antibodies as targeted therapy in hematologic malignancies in older adults.
- Multiple population models for multivariate random length data--with applications in clinical trials.
- N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials.
- New and Established Technology in Focal Ablation of the Prostate: A Systematic Review.
- Novel platelet antiaggregants and the changing landscape of stroke prevention.
- Olanzapine on trial.
- Ovarian preservation by GnRH agonists during chemotherapy: a meta-analysis.
- Patients' willingness to participate in placebo-controlled trials of antihypertensive therapy.
- Perspectives on large-scale cardiovascular clinical trials for the new millennium. The Virtual Coordinating Center for Global Collaborative Cardiovascular Research (VIGOUR) Group.
- Placebo Response and Practice Effects in Schizophrenia Cognition Trials.
- Power considerations for trials of two experimental arms versus a standard active control or placebo.
- Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.
- Proposals of statistical consideration to evaluation of results for a specific region in multi-regional trials--Asian perspective.
- Research on field-based services: models for reform in the delivery of mental health care to populations with complex clinical problems.
- Safety of placebo controls in pediatric hypertension trials.
- Sham trials: benefits and risks for cardiovascular research and patients.
- Short-term trials and long-term effects.
- Star-D: lessons learned and future implications.
- Study protocol for evaluating the effectiveness of depression management on gylcaemic control in non-communicable diseases clinics in Malawi.
- Suicide risk analysis among patients assigned to psychotropics and placebo.
- The Society for Clinical Trials supports United States legislation mandating trials registration. Position paper.
- Therapy of rheumatoid arthritis: new developments and trends.
- Thymectomy for myasthenia gravis: evaluation requires controlled prospective studies.
- Tiotropium (Spiriva) for COPD.
- Update: vinorelbine (navelbine) in non-small cell lung cancer.
- Variation in definitions of urinary tract infections in spina bifida patients: a systematic review.
- Where there's smoke, is there fire?
-
Keywords of People
- Myers, Evan Robert, Walter L. Thomas Distinguished Professor of Obstetrics and Gynecology in the School of Medicine, Duke Cancer Institute
- O'Connor, Christopher Michael, Adjunct Professor in the Department of Medicine, Medicine, Clinical Pharmacology
- Routh, Jonathan Charles, Paul H. Sherman, M.D. Distinguished Associate Professor of Surgery, Pediatrics